GlassScriptPhysician profile
Frederic L Seligson
NPI 1548299621
$4,021.54
in general payments reported to CMS, 2019-2025
17 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,975 · 2020: $248 · 2021: $343 · 2022: $488 · 2023: $426 · 2024: $372 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $968.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $968.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,460.00 | 2019 | |
| Edwards Lifesciences Corporation | $1,018.34 | 2019-2025 | Sapien 3 Ultra Resilia, Konect Resilia, Mitris Resilia Mitral Valve |
| Atricure, INC. | $781.19 | 2019-2025 | Synergy Ablation System, Atricure Cryoice Cryoablation System (Cryo2), Atriclip Laa Exclusion System |
| Medtronic, INC. | $206.77 | 2021-2025 | Corevalve Evolut R, Na |
| Abbott Laboratories | $124.80 | 2020-2023 | Epic |
| Haemonetics Corporation | $94.22 | 2021 | |
| Boston Scientific Corporation | $79.80 | 2019-2022 | |
| Davol INC. | $66.86 | 2019 | |
| Novo Nordisk INC | $44.53 | 2023-2024 | Ozempic, Wegovy |
| Corcym INC | $28.13 | 2022 | |
| Lemaitre Vascular, INC. | $21.56 | 2024 | Restoreflow |
| Alnylam Pharmaceuticals INC. | $20.72 | 2022 | |
| Pfizer INC. | $18.84 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $16.16 | 2023 | |
| Aesculap, INC. | $14.52 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $14.08 | 2025 | Neoview |
| Covidien LP | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederic Seligson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.